CIK 0001598599 · Accelerated filer
Innate Pharma SA
Sign in to watch- Ticker
- IPHYF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- other
- Phone
- 33430303030
- Business address
- 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, France, 13009
- Former names
- Innate Pharma, SA
Securities
- IPHA American Depositary Shares Nasdaq
- IPHYF Common stock OTC
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- F-3 Offering F-3
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- POS EX Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- F-6/A Other F-6/A
- F-6 Other Registration of American Depositary Receipt Shares
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
Page 1 of 2 · 24 filings